1 results ยท Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Venetoclax Treatment (26 Cycles) With 6 Cycles or 12 Cycles of Epcoritamab in Patients With Relapsed or Refractory CLL or SLLchronic lymphocytic leukemia/small lymphocytic lymphomaRecruitingPhase 1 / Phase 22026-10-05NCT05791409